In this video, Dr. Brian G.M. Durie explains how high-dose melphalan therapy that precedes an ASCT may cause some side effects and how an ASCT itself may result in some low-risk complications.
The BOTTOM LINE: Autologous stem cell transplant is still a recommended therapy, if feasible, and it is mostly manageable.
Advertisement